Linked Life Data

19870560

Source:http://linkedlifedata.com/resource/pubmed/id/19870560

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2010-6-23
pubmed:abstractText
1. Guinea pigs can be actively immunized against European typhus fever with homologous formalinized Rickettsia tissue cultures, provided sufficient amounts are injected. The method is suggested for practical application in man. 2. Serovaccination against European typhus fever can be successfully applied to guinea pigs by a variety of methods, the simplest of which consists of the injection of mixtures of virulent defibrinated guinea pig blood and convalescent guinea pig serum taken from 3 to 5 days after defervescence. Similar results can be obtained with mixtures in which tissue culture virus, either with convalescent guinea pig serum or with antimurine horse serum, is used. There is no indication so far that such animals become carriers. Possible application of these methods to typhus epidemics is discussed.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:status
PubMed-not-MEDLINE
pubmed:month
Oct
pubmed:issn
0022-1007
pubmed:author
pubmed:issnType
Print
pubmed:day
31
pubmed:volume
64
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
673-87
pubmed:dateRevised
2010-9-28
pubmed:year
1936
pubmed:articleTitle
FURTHER STUDIES ON TYPHUS FEVER : ON HOMOLOGOUS ACTIVE IMMUNIZATION AGAINST THE EUROPEAN STRAIN OF TYPHUS FEVER.
pubmed:affiliation
Department of Bacteriology and Immunology, The Harvard Medical School, Boston.
pubmed:publicationType
Journal Article